Skip to main content

Table 3 Plasma levels of MDA and SOD (mean ± SD, n = 6)

From: Combined treatment with bone marrow mesenchymal stem cells and methylprednisolone in paraquat-induced acute lung injury

Group MDA (nmol/ml) SOD (U/ml)
  1d 3d 7d 14d 1d 3d 7d 14d
PQ 4.03 ±0.61 a 4.65 ±0.78 a 5.07 ±0.64 a   287.66 ±11.53 a 246.32 ±16.31 a 212.58 ±19.22 a  
BMSC 3.97 ±0.70 b 4.32 ±0.48 c 4.16 ±0.81 c 3.63±0.56 285.17 ±13.69 b 261.24 ±20.74 c 269.74 ±15.64 c 284.42± 17.56
MP 3.82 ±0.58 d 4.49 ±0.46 4.06 ±0.62   294.52 ±10.14 d 265.43 ±15.26 280.15 ±14.58  
BMSC + MP 3.78 ±0.74 4.20 ±0.29 de 3.79 ±0.51 de 3.31±0.68 292.38 ±9.06 278.66 ±11.84 de 302.37 ±10.11 de 304.15± 10.63
Normal control 3.06 ± 0.24 308.29 ± 18.83
  1. Note: a P < 0.01, vs. normal control group; bP > 0.05, c P < 0.01, vs. PQ group; d P < 0.01, vs. BMSC group; e P < 0.01, vs. MP group.